Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bryan V. Redmond has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Ultraweak Photon Emission in the Nervous System: Mechanisms, Disease Relevance, and Translational Opportunities

    by Wiliam Raskopf, Varun Reddy, Owen Tolbert, Bryan V. Redmond

    Ultraweak photon emission (UPE) refers to spontaneous, low-intensity photon release from biological systems, generated largely through oxidative metabolic reactions involving reactive oxygen species, lipid peroxidation, mitochondrial activity, and electronically excited molecular intermediates. Because the nervous system is highly metabolically active and vulnerable to oxidative stress, hypoxia, excitotoxicity, inflammation, and mitochondrial dysfunction, UPE may offer a noninvasive optical window into neural physiology and disease. In this narrative review, we examine experimental and translational evidence linking UPE to nervous system function, with emphasis on neuronal excitation, glutamate-mediated activity, ischemia-reperfusion injury, stroke, neurodegeneration, mental-state and anesthesia paradigms, photobiomodulation, demyelinating disease, Parkinson disease, amyotrophic lateral sclerosis, and neuro-oncology. Across these domains, UPE appears most consistently associated with redox metabolism, mitochondrial function, oxidative stress, and excitation–metabolism coupling, whereas evidence that endogenous photons mediate functional neural signaling remains preliminary. Current data suggest that UPE may be most promising as a preclinical biomarker of tissue metabolic state, delayed post-ischemic dysfunction, and early neurodegenerative change, particularly when integrated with electrophysiology, perfusion imaging, molecular assays, and other physiologic measures. However, clinical translation is limited by low photon flux, limited temporal and spectral resolution, difficulty localizing signals from deep tissue, heterogeneous experimental protocols, and incomplete source attribution. Overall, UPE represents a promising but still early-stage framework for studying nervous system metabolism and disease, with future progress dependent on standardized methods, multimodal validation, and disease-specific investigation.

  • Open Access

    Takotsubo Cardiomyopathy: Current Perspectives on Pathophysiology, Diagnosis, Technology, and Management

    by Filip D. Koritysskiy, Bryan V. Redmond

    Takotsubo cardiomyopathy (TCM), also known as stress cardiomyopathy or "broken heart syndrome," is a transient form of acute heart failure that mimics acute coronary syndrome (ACS) but typically occurs without obstructive coronary artery disease. Though once considered rare, TCM is increasingly recognized in clinical practice, particularly among postmenopausal women. Despite its rising incidence, significant knowledge gaps remain in its pathophysiology, diagnosis, management, and long-term outcomes. A contemporary understanding of TCM is critical for clinicians to accurately differentiate it from other acute cardiac conditions and provide patient-centered care. This narrative review synthesizes the current literature on TCM, with a focus on evolving theories of pathophysiology, including catecholamine surge and neurocardiac axis dysfunction, alongside emerging diagnostic strategies which may implicate microvascular involvement. We examine the expanding role of cardiac imaging modalities and biomarker profiles in differentiating TCM from ACS, as well as current best practices in acute and long-term management.

  • Open Access

    Vision‐related quality of life after unilateral occipital stroke

    by Neil Dogra, Bryan V. Redmond, Selena Lilley, Brent A. Johnson, Byron L. Lam, Madhura Tamhankar, Steven E. Feldon, Berkeley Fahrenthold, Jingyi Yang, Krystel R. Huxlin, et al.

    Background/objectives: Stroke damage to the primary visual cortex induces large, homonymous visual field defects that impair daily living. Here, we asked if vision‐related quality of life (VR‐QoL) is impacted by time since stroke.Subjects/methods: We conducted a retrospective meta‐analysis of 95 occipital stroke patients (female/male = 26/69, 27–78 years old, 0.5–373.5 months poststroke) in whom VR‐QoL was estimated using the National Eye Institute Visual Functioning Questionnaire (NEI‐VFQ) and its 10‐item neuro‐ophthalmic supplement (Neuro10). Visual deficit severity was represented by the perimetric mean deviation (PMD) calculated from 24‐2 Humphrey visual fields. Data were compared with published cohorts of visually intact controls. The relationship between VR‐QoL and time poststroke was assessed across participants, adjusting for deficit severity and age with a multiple linear regression analysis.Results: Occipital stroke patients had significantly lower NEI‐VFQ and Neuro10 composite scores than controls. All subscale scores describing specific aspects of visual ability and functioning were impaired except for ocular pain and general health, which did not differ significantly from controls. Surprisingly, visual deficit severity was not correlated with either composite score, both of which increased with time poststroke, even when adjusting for PMD and age.Conclusions: VR‐QoL appears to improve with time postoccipital stroke, irrespective of visual deficit size or patient age at insult. This may reflect the natural development of compensatory strategies and lifestyle adjustments. Thus, future studies examining the impact of rehabilitation on daily living in this patient population should consider the possibility that their VR‐QoL may change gradually over time, even without therapeutic intervention.


  • Open Access

    The Garlic Compound, Diallyl Trisulfide, Attenuates Benzo[a]Pyrene-Induced Precancerous Effect through Its Antioxidant Effect, AhR Inhibition, and Increased DNA Repair in Human Breast Epithelial Cells

    by Dominique T. Ferguson, Equar Taka, Samia Messeha, Hernan Flores-Rozas, Sarah L. Reed, Bryan V. Redmond, Karam F. A. Soliman, Konan J. W. Kanga, Selina F. Darling-Reed

    Exposure to B[a]P, the most characterized polycyclic aromatic hydrocarbon, significantly increases breast cancer risk. Our lab has previously reported that diallyl trisulfide (DATS), a garlic organosulfur compound (OSC) with chemopreventive and cell cycle arrest properties, reduces lipid peroxides and DNA damage in normal breast epithelial (MCF-10A) cells. In this study, we evaluated the ability of DATS to block the B[a]P-induced initiation of carcinogenesis in MCF-10A cells by examining changes in proliferation, clonogenic formation, reactive oxygen species (ROS) formation, 8-hydroxy-2-deoxyguanosine (8-OHdG) levels, and protein expression of ARNT/HIF-1β, CYP1A1, and DNA POLβ. The study results indicate that B[a]P increased proliferation, clonogenic formation, ROS formation, and 8-OHdG levels, as well as increasing the protein expression of ARNT/HIF-1β and CYP1A1 compared to the control. Conversely, DATS/B[a]P co-treatment (CoTx) inhibited cell proliferation, clonogenic formation, ROS formation, and 8-OHdG levels compared to B[a]P alone. Treatment with DATS significantly inhibited (p < 0.0001) AhR expression, implicated in the development and progression of breast cancer. The CoTx also attenuated all the above-mentioned B[a]P-induced changes in protein expression. At the same time, it increased DNA POLβ protein expression, which indicates increased DNA repair, thus causing a chemopreventive effect. These results provide evidence for the chemopreventive effects of DATS in breast cancer prevention.


  • Open Access

    The Anticancer Effects of the Garlic Organosulfide Diallyl Trisulfide through the Attenuation of B[a]P-Induced Oxidative Stress, AhR Expression, and DNA Damage in Human Premalignant Breast Epithelial (MCF-10AT1) Cells

    by Dominique T. Ferguson, Equar Taka, Syreeta L. Tilghman, Tracy Womble, Bryan V. Redmond, Shasline Gedeon, Hernan Flores-Rozas, Sarah L. Reed, Karam F. A. Soliman, Konan J. W. Kanga, et al.

    Benzo[a]pyrene (B[a]P) is the most characterized polycyclic aromatic hydrocarbon associated with breast cancer. Our lab previously reported that the organosulfur compound (OSC), diallyl trisulfide (DATS), chemoprevention mechanism works through the induction of cell cycle arrest and a reduction in oxidative stress and DNA damage in normal breast epithelial cells. We hypothesize that DATS will inhibit B[a]P-induced cancer initiation in premalignant breast epithelial (MCF-10AT1) cells. In this study, we evaluated the ability of DATS to attenuate B[a]P-induced neoplastic transformation in MCF-10AT1 cells by measuring biological endpoints such as proliferation, clonogenicity, reactive oxygen species (ROS) formation, and 8-hydroxy-2-deoxyguanosine (8-OHdG) DNA damage levels, as well as DNA repair and antioxidant proteins. The results indicate that B[a]P induced proliferation, clonogenic formation, ROS formation, and 8-OHdG levels, as well as increasing AhR, ARNT/HIF-1β, and CYP1A1 protein expression compared with the control in MCF-10AT1 cells. B[a]P/DATS’s co-treatment (CoTx) inhibited cell proliferation, clonogenic formation, ROS formation, AhR protein expression, and 8-OHdG levels compared with B[a]P alone and attenuated all the above-mentioned B[a]P-induced changes in protein expression, causing a chemopreventive effect. This study demonstrates, for the first time, that DATS prevents premalignant breast cells from undergoing B[a]P-induced neoplastic transformation, thus providing more evidence for its chemopreventive effects in breast cancer.


  • Open Access

    The Natural History of Vision-Related Quality of Life after Unilateral Occipital Stroke

    by Neil Dogra, Bryan V. Redmond, Selena Lilley, Brent A. Johnson, Byron L. Lam, Madhura Tamhankar, Steven E. Feldon, Berkeley K Fahrenthold, Jingyi Yang, Krystel R. Huxlin, et al.

    Background/Objectives: Stroke damage to the primary visual cortex induces large, homonymous visual field defects that impair daily living. Here, we asked if vision-related quality of life (V-QoL) is impacted by time since stroke. Subjects/Methods: We conducted a retrospective meta-analysis of 95 occipital stroke patients (F/M=26/69, 27-78 years old, 0.5 to 373.5 months post-stroke) in whom V-QoL was estimated using the National Eye Institute Visual Functioning Questionnaire (NEI-VFQ) and its 10-item neuro-ophthalmic supplement (Neuro10). Visual deficit severity was represented by the Perimetric Mean Deviation (PMD) calculated from 24-2 Humphrey visual fields. Data were compared with published cohorts of visually-intact controls. The relationship between V-QoL and time post-stroke was assessed across participants, adjusting for deficit severity and age with a multiple linear regression analysis. Results: Occipital stroke patients had significantly lower NEI-VFQ and Neuro10 composite scores than controls. All subscale scores describing specific aspects of visual ability and functioning were impaired except for ocular pain and general health, which did not differ significantly from controls. Surprisingly, visual deficit severity was not correlated with either composite score, both of which increased with time post-stroke, even when adjusting for PMD and age. Conclusions: V-QoL appears to improve with time post-occipital stroke, irrespective of visual deficit size or patient age at insult. This may reflect the natural development of compensatory strategies and lifestyle adjustments. Thus, future studies examining the impact of rehabilitation on daily living in this patient population should consider the possibility that their V-QoL may change gradually over time, even without therapeutic intervention.